Literature DB >> 18435794

Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblings.

Y Miyoshi1, M Akagi, A K Agarwal, N Namba, K Kato-Nishimura, I Mohri, M Yamagata, S Nakajima, S Mushiake, M Shima, R J Auchus, M Taniike, A Garg, K Ozono.   

Abstract

Mandibuloacral dysplasia (MAD) is a rare autosomal recessive progeroid syndrome, characterized by mandibular hypoplasia, acroosteolysis affecting distal phalanges and clavicles, delayed closure of the cranial sutures, atrophic skin, and lipodystrophy. Recently, mutations in lamin A/C (LMNA) and zinc metalloprotease (ZMPSTE24), involved in post-translational processing of prelamin A to mature lamin A, have been identified in MAD kindreds. We now report novel compound heterozygous mutations in exon 1 (c.121C>T; p.Q41X) and exon 6 (c.743C>T; p.P248L) in ZMPSTE24 in two Japanese sisters, 7- and 3-year old, with severe MAD and characteristic facies and atrophic skin. The older sister had lipodystrophy affecting the chest and thighs but sparing abdomen. Their parents and a brother, who were healthy, had heterozygous mutations. The missense mutation, P248L, was not found in 100 normal subjects of Japanese origin. The mutant Q41X was inactive in a yeast halo assay; however, the mutant P248L retained near normal ZMPSTE24 activity. Immunoblots demonstrated accumulation of prelamin A in the patients' cell lysates from lymphoblasts. The lymphoblasts from the patients also revealed less intense staining for lamin A/C on immunofluorescence. We conclude that ZMPSTE24 deficiency results in accumulation of farnesylated prelamin A, which may be responsible for cellular toxicity and the MAD phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435794      PMCID: PMC2732118          DOI: 10.1111/j.1399-0004.2008.00992.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  33 in total

1.  Mandibuloacral dysplasia caused by homozygosity for the R527H mutation in lamin A/C.

Authors:  J J Shen; C A Brown; J R Lupski; L Potocki
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

2.  Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome.

Authors:  M Plasilova; C Chattopadhyay; P Pal; N A Schaub; S A Buechner; Hj Mueller; P Miny; A Ghosh; K Heinimann
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

3.  Another Italian family with mandibuloacral dysplasia: why does it seem more frequent in Italy?

Authors:  R Tenconi; F Miotti; A Miotti; G Audino; R Ferro; M Clementi
Journal:  Am J Med Genet       Date:  1986-06

4.  New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys.

Authors:  L W Young; J F Radebaugh; P Rubin; J A Sensenbrenner; G Fiorelli; V A McKusick
Journal:  Birth Defects Orig Artic Ser       Date:  1971-06

5.  Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect.

Authors:  Martin O Bergo; Bryant Gavino; Jed Ross; Walter K Schmidt; Christine Hong; Lonnie V Kendall; Andreas Mohr; Margarita Meta; Harry Genant; Yebin Jiang; Erik R Wisner; Nicholas Van Bruggen; Richard A D Carano; Susan Michaelis; Stephen M Griffey; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

6.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.

Authors:  Claire L Navarro; Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Irène Boccaccio; Amandine Boyer; David Geneviève; Smail Hadj-Rabia; Caroline Gaudy-Marqueste; Henk Sillevis Smitt; Pierre Vabres; Laurence Faivre; Alain Verloes; Ton Van Essen; Elisabeth Flori; Raoul Hennekam; Frits A Beemer; Nicole Laurent; Martine Le Merrer; Pierre Cau; Nicolas Lévy
Journal:  Hum Mol Genet       Date:  2004-08-18       Impact factor: 6.150

7.  Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.

Authors:  Anil K Agarwal; Jean-Pierre Fryns; Richard J Auchus; Abhimanyu Garg
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

8.  Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.

Authors:  Vinaya Simha; Anil K Agarwal; Elif Arioglu Oral; Jean-Pierre Fryns; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia.

Authors:  G R Freidenberg; D L Cutler; M C Jones; B Hall; R J Mier; F Culler; K L Jones; C Lozzio; S Kaufmann
Journal:  Am J Dis Child       Date:  1992-01

10.  LMNA mutations in atypical Werner's syndrome.

Authors:  Lishan Chen; Lin Lee; Brian A Kudlow; Heloisa G Dos Santos; Olav Sletvold; Yousef Shafeghati; Eleanor G Botha; Abhimanyu Garg; Nancy B Hanson; George M Martin; I Saira Mian; Brian K Kennedy; Junko Oshima
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

View more
  19 in total

1.  Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation.

Authors:  Rabah Ben Yaou; Claire Navarro; Susana Quijano-Roy; Anne T Bertrand; Catherine Massart; Annachiara De Sandre-Giovannoli; Juan Cadiñanos; Kamel Mamchaoui; Gillian Butler-Browne; Brigitte Estournet; Pascale Richard; Annie Barois; Nicolas Lévy; Gisèle Bonne
Journal:  Eur J Hum Genet       Date:  2011-01-26       Impact factor: 4.246

Review 2.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

3.  Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24.

Authors:  Zahid Ahmad; Elaine Zackai; Livija Medne; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2010-11       Impact factor: 2.802

4.  Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity.

Authors:  Jemima Barrowman; Patricia A Wiley; Sarah E Hudon-Miller; Christine A Hrycyna; Susan Michaelis
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

5.  Homozygous null mutations in ZMPSTE24 in restrictive dermopathy: evidence of genetic heterogeneity.

Authors:  Z Ahmad; S R Phadke; E Arch; J Glass; A K Agarwal; A Garg
Journal:  Clin Genet       Date:  2010-11-25       Impact factor: 4.438

6.  Atypical progeroid syndrome due to heterozygous missense LMNA mutations.

Authors:  Abhimanyu Garg; Lalitha Subramanyam; Anil K Agarwal; Vinaya Simha; Benjamin Levine; Maria Rosaria D'Apice; Giuseppe Novelli; Yanick Crow
Journal:  J Clin Endocrinol Metab       Date:  2009-10-29       Impact factor: 5.958

7.  HIV-protease inhibitors block the enzymatic activity of purified Ste24p.

Authors:  Sarah E Hudon; Catherine Coffinier; Susan Michaelis; Loren G Fong; Stephen G Young; Christine A Hrycyna
Journal:  Biochem Biophys Res Commun       Date:  2008-07-17       Impact factor: 3.575

8.  New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.

Authors:  Claire Laure Navarro; Vera Esteves-Vieira; Sébastien Courrier; Amandine Boyer; Thuy Duong Nguyen; Le Thi Thanh Huong; Peter Meinke; Winnie Schröder; Valérie Cormier-Daire; Yves Sznajer; David J Amor; Kristina Lagerstedt; Martine Biervliet; Peter C van den Akker; Pierre Cau; Patrice Roll; Nicolas Lévy; Catherine Badens; Manfred Wehnert; Annachiara De Sandre-Giovannoli
Journal:  Eur J Hum Genet       Date:  2013-10-30       Impact factor: 4.246

9.  Phenotypic heterogeneity of ZMPSTE24 deficiency.

Authors:  Thomas A Cassini; Amy K Robertson; Anna G Bican; Joy D Cogan; Vickie L Hannig; John H Newman; Rizwan Hamid; John A Phillips
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

Review 10.  Lipodystrophies: disorders of adipose tissue biology.

Authors:  Abhimanyu Garg; Anil K Agarwal
Journal:  Biochim Biophys Acta       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.